LONAPRISAN(211254-73-8)
- Name: LONAPRISAN
- Synonyms:11β-(4-Acetylphenyl)-20,20,21,21,21-pentafluoro-17-hydroxy-19-nor-17α-pregna-4,9-dien-3-one;Lonaprisan;ZK 230211;
- Molecular Formula:C28H29F5O3
- Molecular Weight:508.528
- CAS Registry Number:211254-73-8
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.211254-73-8 LONAPRISAN
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)] CAS No.211254-73-8 LONAPRISAN
Assay:99% Package:box or opp package Storage:cool drum Transportation:air or sea Application:LONAPRISAN
Min. Order:1Milligram
Supplier:weifang yangxu group co.,ltd [
China (Mainland)] CAS No.211254-73-8 Lonaprisan cas 211254-73-8
Assay:98% Application:Inhibitor
Min. Order:0Metric Ton
Supplier:BOC Sciences [
United States]
Other Product
- 870524-46-2/DNA (synthetic plasmid p3kDRαHPV16-18)
- 627861-07-8/Beperminogene perplasmid (9CI)
- 769901-96-4/1,3,4-Oxadiazol-2(3H)-one, 5-(8-amino-7-chloro-2,3-dihydro-1,4-benzodioxin-5-yl)-3-[1-(2-phenylethyl)-4-piperidinyl]-
- 872847-66-0/DNA, d(P-thio)(C-C-C-T-G-C-T-C-C-C-C-C-C-T-G-G-C-T-C-C), nonadecasodium salt (9CI)
- 544417-40-5/CAPADENOSON
- 338990-84-4/1-[3(R)-[4-(4-Cyanophenyl)thiazol-2-yl]-2(R)-(2,5-difluorophenyl)-2-hydroxybutyl]-4-[1-[N-methyl-N-[3-[2-(methylammonio)acetoxymethyl]pyridin-2-yl]carbamoyloxy]ethyl]-1H-1,2,4-triazol-4-ium dichloride
- 355151-12-1/Glycinamide, N-acetyl-D-tyrosyl-D-prolyl-(4S)-4-hydroxy-D-prolylglycyl-D-alanyl-
- 497221-38-2/L-Valinamide, L-alanylglycyl-L-tyrosyl-L-lysyl-L-prolyl-L-α-aspartyl-L-α-glutamylglycyl-L-lysyl-L-arginylglycyl-L-α-aspartyl-L-alanyl-L-cysteinyl-L-α-glutamylglycyl-L-α-aspartyl-L-serylglycylglycyl-L-prolyl-L-phenylalanyl-
- 872178-65-9/Rob 803
- 625114-41-2/Benzeneacetamide, 3-chloro-4-(methylsulfonyl)-α-[[(1R)-3-oxocyclopentyl]methyl]-N-2-pyrazinyl-, (αR)-
- 552292-08-7/Rolapitant
- 579475-18-6/orvepitant
- 481629-87-2/1H-Indole-3-acetic acid, 1-[[4-(1,1-dimethylethyl)phenyl]methyl]-5-(3-methylphenyl)-α-oxo-
- 318498-76-9/(3R,4R,5E,10E,12E,14S,16R,26aR)-16-Fluoro-14-hydroxy-3-isopropyl-4,12-dimethyl-3,4,8,9,14,15,16,17,24,25,26,26a-dodecahydro-7H-21,18-nitrilo-1H,22H-pyrrolo[2,1-c][1,8,4,19]dioxadiazacyclotetracosine-1,7,22-trione
- 325965-23-9/5-[(2S)-1,2,3,6-Tetrahydro-5-(4-morpholinylmethyl)-2-pyridinecarboxylic acid]pristinamycin IA
- 442201-24-3/ReMogliflozin etabonate
- 677017-23-1/WP 769
- 187852-63-7/Glycinamide, glycylglycyl-N-[3-[[(4S)-4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl]oxy]propyl]-, compd. with dextran carboxymethyl ether sodium salt
- 9007-72-1/Injectafer
- 211254-73-8/LONAPRISAN
- 218949-48-5/Tesamorelin (usan)
- 172740-14-6/5-Heptenoic acid, 7-[(1R,2S)-2-[(1E,3S)-3-hydroxy-5-phenyl-1-penten-1-yl]-5-oxo-3-cyclopenten-1-yl]-, 1-methylethyl ester, (5Z)-
- 333963-42-1/Cobiprostone
- 348119-84-6/L-Tyrosinamide, L-alanyl-L-prolyl-L-leucyl-L-α-glutamyl-L-prolyl-L-valyl-L-tyrosyl-L-prolylglycyl-L-α-aspartyl-L-asparaginyl-L-alanyl-L-threonyl-L-prolyl-L-α-glutamyl-L-glutaminyl-L-methionyl-L-alanyl-L-glutaminyl-L-tyrosyl-L-alanyl-L-alanyl-L-α-aspartyl-L-leucyl-L-arginyl-L-arginyl-L-tyrosyl-L-isol...
- 398507-55-6/Lodenafil carbonate
- 691852-58-1/5-Cyclopropyl-2-(4-fluorophenyl)-6-[(2-hydroxyethyl)(methylsulfonyl)amino]-N-methyl-3-benzofurancarboxamide
- 839673-52-8/1H-Indole-2-carboxylic acid, 2,3-dihydro-1-[[4-[[5-methyl-2-[4-(trifluoromethyl)phenyl]-4-oxazolyl]methoxy]phenyl]sulfonyl]-, (2R)-
- 872525-61-6/Histamine-binding protein rEV131 (synthetic Rhipicephalus appendiculatus saliva) (9CI)
- 904302-98-3/3-Piperidinecarboxylic acid, 4-[(3S)-3-(3-fluoro-6-methoxy-4-quinolinyl)-3-hydroxypropyl]-1-[2-(2-thienylthio)ethyl]-, (3R,4R)-
- 925681-61-4/DNA, d(P-thio)(C-G-G-C-A-T-G-T-C-T-A-T-T-T-T-G-T-A)